Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.538%)
Open: 32.75
High: 0.00
Low: 0.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction: Appointment and Issue of Shares

29 Oct 2015 07:00

RNS Number : 7859D
Duke Royalty Limited
29 October 2015
 



29 October 2015

This announcement replaces the Company's announcement issued under RNS number 6322D at 07.00 on 28 October 2015 (the "Previous Announcement"). The Previous Announcement stated that following the Share Issue, Mr Cochrane will hold 250,000 Ordinary Shares, representing 3.17 per cent of the entire issued share capital. The Previous Announcement should have stated that following the Share Issue, Mr Cochrane will hold 300,000 Ordinary Shares, representing 3.81 per cent of the entire issued share capital.

The full amended announcement is set out below. All other details remain unchanged.

Duke Royalty Limited

("Duke Royalty" or the "Company")

 

Correction: Mr Justin Cochrane Appointment and Issue of Shares

 

Duke Royalty is pleased to announce that Justin Cochrane, a current member of the Company's Healthcare Investment Committee, has agreed to join Abingdon Capital Corporation ('Abingdon') as Executive Vice President, Corporate Development on a full time basis. Abingdon is a financial advisory company, which provides support services to the Company in respect of global deal origination, vertical partner relationships and on-going investment management, including preparation of investment reports, performance data and compliance with the Company's investing policy. Through his position at Abingdon, Mr Cochrane will play a pivotal role in the roll-out and execution of the Duke Royalty business plan and will bring significant royalty based experience to the operational team.

Mr Cochrane has negotiated, structured and executed dozens of royalty transactions in multiple jurisdictions during his five years at Sandstorm Gold Limited where he was Executive Vice President of Corporate Development. From 2002 to 2010 Mr Cochrane worked for National Bank Financial Inc. where he gained significant transaction experience executing M&A and capital markets transactions including IPO's for the income trust and royalty sectors, among others. Mr Cochrane holds a Bachelor of Commerce (finance major) from the University of British Columbia and has received a CFA designation from the CFA Institute.

In his new role, Mr Cochrane will have an active involvement in the due diligence of prospective investment opportunities for Duke Royalty; assisting in the execution of royalty transactions approved by the Duke Royalty board and in the monitoring of royalty investments made by the Company.

The Duke Royalty Board has approved the issue of 250,000 new Duke Royalty ordinary shares of no par value each in the Company ("Ordinary Shares") to Mr Cochrane (the "Share Issue") as a signing bonus, further cementing his alignment with shareholders.

Application has been made for the 250,000 new Ordinary Shares to be admitted to trading on AIM with admission expected to take place on or around 3 November 2015 ("Admission").

Following the Share Issue, Mr Cochrane will hold 300,000 Ordinary Shares, representing 3.81 per cent of the entire issued share capital.

Following Admission, there will be 7,877,459 Ordinary Shares in issue. The Company does not hold any shares in treasury. Therefore the total number of shares with voting rights in the Company following Admission will be 7,877,459. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information:

Duke Royalty Limited

Neil Johnson

Charlie Cannon-Brookes

+44 (0) 1481 741 240

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson/ Jamie Barklem/ Daniel Bush

+44 (0)20 7383 5100

 

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited is a team of experienced financial executives dedicated to providing royalty financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty has reinvented the royalty financing model for the European public markets through its efficient corporate structure and exclusive alliances and partnerships that provide both deal flow and expertise. Duke Royalty's investments are intended to provide robust, stable, long-term returns to its shareholders.

 

Duke Royalty is listed on the AIM market under the ticker DUKE. For more information, visit dukeroyalty.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEDFAAFISEIS
Date   Source Headline
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update
21st Jun 20227:00 amRNSInterim Dividend and Dividend Declaration
1st Jun 20224:25 pmRNSHolding(s) in Company
27th May 20229:08 amRNSDirector / PCA Dealings
26th May 20223:23 pmRNSResult of General Meeting and Issue of Equity
11th May 20227:05 amRNSRaises £20m through Placing and PrimaryBid Offer
10th May 20225:08 pmRNSPrimaryBid Offer
10th May 20224:44 pmRNSPlacing to raise a minimum of £15 million
28th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
20th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
11th Apr 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Mar 20227:00 amRNSIncreased Interim Dividend & Dividend Declaration
2nd Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
25th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Feb 20227:00 amRNSFurther re: Directorate Change
14th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
2nd Feb 20227:00 amRNSDirectorate Changes
1st Feb 202210:02 amRNSReplacement - Trading Update
1st Feb 20227:00 amRNSTrading Update
20th Jan 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
23rd Dec 20212:30 pmRNSHolding(s) in Company
23rd Dec 20217:01 amRNSTrading Update
23rd Dec 20217:00 amRNSFollow-on investment into existing Royalty Partner
22nd Dec 20213:52 pmRNSFollow-on investment into existing Royalty Partner
16th Dec 20217:00 amRNSNew Royalty Agreement
14th Dec 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
7th Dec 20217:00 amRNSEnters into Largest Royalty Agreement To Date
3rd Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSCompletion of £4.2 million Follow-On Investment
25th Nov 20217:00 amRNSNotice of Interim Results
29th Oct 20214:03 pmRNSLong Term Incentive Plan Awards
27th Oct 20217:01 amRNSFollow-On Investment into Existing Royalty Partner
27th Oct 20217:00 amRNSHolding(s) in Company
22nd Oct 20214:36 pmRNSResult of Annual General Meeting
16th Sep 20217:01 amRNSInterim Dividend and Dividend Declaration
16th Sep 20217:00 amRNSFinal Results
7th Sep 20217:00 amRNS£2.2m Follow-On Investment into Royalty Partner
2nd Sep 20217:00 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSInvestor Presentation
11th Aug 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Aug 20217:00 amRNSNew Royalty Agreement
26th Jul 20217:00 amRNSTrading Update
22nd Jul 20217:00 amRNSNew Royalty Agreement
1st Jul 20217:00 amRNSNew Royalty Agreement with Fairmed Healthcare AG
17th Jun 20217:00 amRNSInterim Dividend and Dividend Declaration
10th May 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.